Anna Berkenblit - 14 May 2025 Form 4 Insider Report for Surrozen, Inc./DE (SRZN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 May 2025, 17:07:04 UTC
Prior SEC filing
06 Jun 2024
Next SEC filing
14 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/Charles Williams, Attorney-in-Fact for Anna Berkenblit

Key filing fact

Anna Berkenblit filed Form 4 for Surrozen, Inc./DE (SRZN) on 15 May 2025.

Key facts

  • This page summarizes Anna Berkenblit's Form 4 filing for Surrozen, Inc./DE (SRZN).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 15 May 2025, 17:07.

Change

  • Previous filing in this sequence was filed on 06 Jun 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001691868 Primary reporting owner

Berkenblit Anna

Relationship
Director
Address
C/O SURROZEN, INC., 171 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO
Signature
/s/Charles Williams, Attorney-in-Fact for Anna Berkenblit
Signature date
15 May 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SRZN transaction Derivative

Option (right to buy)

Award

Transaction value
$0
Shares
+1,333
Change %
Price
$0.000000
Shares after
1,333
Date
14 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,333
Exercise price
$6.50
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The options vest and become exercisable on the anniversary of the grant date, subject to continuous service as a director.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .